Back to Results
First PageMeta Content
Microbiology / Tuberculosis diagnosis / European and Developing Countries Clinical Trials Partnership / Extensively drug-resistant tuberculosis / TB Alliance / Multi-drug-resistant tuberculosis / Foundation for Innovative New Diagnostics / Mantoux test / Mycobacterium tuberculosis / Tuberculosis / Bacteria / Medicine


TB Diagnostics EDCTP Stakeholders Meeting Paris – France 7 October 2008
Add to Reading List

Document Date: 2009-01-29 07:31:25


Open Document

File Size: 310,60 KB

Share Result on Facebook

City

Dar es Salaam / Paris / Studi di Brescia / Amsterdam / Geneva / Johannesburg / Liverpool / Nairobi / Berlin / Antwerp / Banjul / /

Company

Knoll Pharmaceutical Company / Rapid Biosensor Systems / The Medicines Company / Team / 4SC AG / The Gambia National TB Reference Laboratory / BASF Pharma / Global Laboratory / Biotec Inc. / Developing Countries Clinical Trials Partnership / Scientific / BD Pharmaceuticals / /

Continent

Africa / Asia / /

Country

Switzerland / Netherlands / South Africa / France / United Kingdom / Denmark / Germany / Sweden / Belgium / United States / Spain / /

Event

Employment Change / /

Facility

UK Institute of Tropical Medicine / Belgium Windeyer Institute of Medical Research / University of Cape Town / South Africa University College of London / University of Munich / Capacity building / UK University of Cape Town / Kenya Medical Research Institute / Program National Institute / Germany Karolinska University / Tanzania NIMR/ Muhimbili Centre / University of Oslo / /

IndustryTerm

laboratory infrastructure / pharmaceutical industry / development chain / quality diagnostic services / value chain / bank / diagnostic tools / liquid culture systems / prepared media / technology platforms / laboratory networks / headspace gas / grant applications / diagnostic algorithms / diagnostic technologies / referral systems / patient management / study protocols / laboratory services / colorimetric media / upstream research products / /

MedicalCondition

HIV / delayed type hypersensitivity / malaria / active TB / latent TB infection / extra pulmonary TB Adenosine deaminase activity / HIV/AIDS / TB pleuritis / TB / M. tuberculosis infection/ disease / M. tuberculosis infection / MS / XDR-TB / Mycobacterium tuberculosis / high disease / infectious form / tuberculosis / /

MedicalTreatment

vaccination / /

Organization

Lung Disease / Stop TB Department / South Africa University College of London / University of Cape Town / Program National Institute for Medical Research / World Health Organisation / Muhimbili Centre / Union against TB / Belgium Windeyer Institute of Medical Research / Tanzania Kilimanjaro Clinical Research Centre / University of Oslo / Foundation for Innovative New Diagnostics / UK Institute of Tropical Medicine / University of Munich / Institut Pasteur / Norway Liverpool School of Tropical Medicine / TB Alliance / London School of Hygiene and Tropical Medicine / Tanzania Medical Research Council / Global Alliance for TB Drug Development / Institute for Infection-Biology / Scientific Advisory Board of 4SC AG / Kenya Medical Research Institute / Germany Karolinska University / /

Person

Melvin Spigelman / Mel Spigelman / Stefan Kauffman / Catharine Boehme / Marc Jouan / Christian Lienhardt / Charles Mgone / Max Planck / Keertan Dheda / Tom Nyirenda / Karin Weyer / /

/

Position

Operations Manager / Executive Director / Scientist and Team Leader / Author / local physician / Professor / chairperson / CEO and President / Director the responsibility / meeting chairperson / Director of Research and Development / Executive Committee / Executive Director and Operations Manager / cofunding procedure The Joint Programme Manager / /

Product

isoniazid / Adenosine / /

PublishedMedium

Proteomics / /

Region

sub-Saharan Africa / South Africa / /

Technology

Proteomics / metabolomics / hybridization / study protocols / glycomics / lipidomics / Drug Development / /

SocialTag